-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Deciphera Pharmaceuticals, Inc. quarterly/annual Costs and Expenses history and growth rate from Q2 2019 to Q1 2024.
- Deciphera Pharmaceuticals, Inc. Costs and Expenses for the quarter ending March 31, 2024 was $93.8M, a 8.24% increase year-over-year.
- Deciphera Pharmaceuticals, Inc. Costs and Expenses for the twelve months ending March 31, 2024 was $381M, a 16.5% increase year-over-year.
- Deciphera Pharmaceuticals, Inc. annual Costs and Expenses for 2023 was $374M, a 18.2% increase from 2022.
- Deciphera Pharmaceuticals, Inc. annual Costs and Expenses for 2022 was $317M, a 20.1% decline from 2021.
- Deciphera Pharmaceuticals, Inc. annual Costs and Expenses for 2021 was $396M, a 26.5% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)